Investigating the evolution of antimicrobial resistance
Social Links:
I am part of the MRC Doctoral Antimicrobial Research Training (DART) iCASE Programme. My PhD project investigates how to control major bacterial pathogens that cause hospital-acquired infections in a partnership between the Quadram Institute and GAMA Healthcare.
The project focuses on understanding the responses of key pathogens to major anti-infective agents to improve infection control. TraDis-Xpress will be applied here to study the role of essential and non-essential genes under specific stress conditions. The overall aim of my project is to prevent the threat of biocide resistance and help develop the next generation of infection control products to ultimately tackle antimicrobial resistance (AMR).
Prior to joining QIB, I graduated from the Universitat Autònoma de Barcelona (UAB) in 2018 with a Bachelor’s Degree in Microbiology. In 2019, I completed an MSc in Molecular Medicine at Trinity College Dublin.